Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Kintara Therapeutics, Inc. (DMPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/11/2023 8-K Quarterly results
Docs: "SUMMARY OF FINANCIAL RESULTS FOR FISCAL YEAR 2023 THIRD QUARTER ENDED MARCH 31, 2023 As of March 31, 2023, Kintara had cash and cash equivalents of approximately $3.0 million. For the three months ended March 31, 2023, Kintara reported a net loss of approximately $3.3 million, or $1.94 per share, compared to a net loss of approximately $5.4 million, or $5.45 per share, for the three months ended March 31, 2022. For the nine months ended March 31, 2023, Kintara reported a net loss of approximately $11.3 million, or $7.32 per share, compared to a net loss of approximately $17.2 million, or $22.39 per share, for the nine months ended March 31, 2022. The decreased net losses for the three and nine months ended March 31, 2023 compared to the three and nine months ended March 31, 2022 was largel..."
02/14/2023 8-K Quarterly results
Docs: "SUMMARY OF FINANCIAL RESULTS FOR FISCAL YEAR 2023 SECOND QUARTER ENDED DECEMBER 31, 2022 As of December 31, 2022, Kintara had cash and cash equivalents of approximately $4.9 million. For the three months ended December 31, 2022, Kintara reported a net loss of approximately $3.5 million, or $2.10 per share, compared to a net loss of approximately $5.9 million, or $6.07 per share, for the three months ended December 31, 2021. For the six months ended December 31, 2022, Kintara reported a net loss of approximately $8.1 million, or $5.42 per share, compared -1- to a net loss of approximately $11.9 million, or $17.30 per share, for the six months ended December 31, 2021. The decreased net losses for the three and six months ended December 31, 2022 compared to the three and six months ended Dece..."
11/09/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
02/11/2022 8-K Quarterly results
Docs: "Kintara Therapeutics Announces Fiscal 2022 Second Quarter Financial Results and Provides Corporate Update"
11/15/2021 8-K Quarterly results
Docs: "Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update"
05/14/2021 8-K Quarterly results
11/13/2020 8-K Quarterly results
Docs: "Kintara Therapeutics Announces First Fiscal Quarter 2021 Financial Results and Recent Corporate Updates"
09/21/2020 8-K Quarterly results
09/10/2019 8-K Quarterly results
05/15/2019 8-K Quarterly results
Docs: "PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED MAY 15, 2019"
02/12/2019 8-K Quarterly results
Docs: "PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED FEBRUARY 12, 2019"
09/24/2018 8-K Quarterly results
Docs: "PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED SEPTEMBER 24, 2018"
05/17/2018 8-K Quarterly results
Docs: "PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED MAY 17, 2018"
02/15/2018 8-K Quarterly results
Docs: "PRESS RELEASE OF DELMAR PHARMACEUTICALS, INC. ISSUED FEBRUARY 14, 2018"
11/17/2016 8-K Form 8-K - Current report
05/19/2016 8-K Form 8-K - Current report
02/18/2016 8-K Quarterly results
Docs: "DelMar Pharmaceuticals Announces Second Quarter Fiscal Year 2016 Financial Results and Corporate Update",
"Presentation"
11/19/2015 8-K Quarterly results
Docs: "DelMar Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update"
05/22/2015 8-K Quarterly results
Docs: "DelMar Pharmaceuticals Announces Third Quarter Fiscal Year 2015 Financial Results and Provides Corporate Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy